Concord Health Partners Expands Senior Team, Adds Healthcare Investing Veterans Erik Larsen and Derek Schmidt

0

Open Nashville, TN Desk

SUMMIT, NJ, July 14, 2022 /PRNewswire/ — Concord Health Partners (“Concorde” or the “Company”), a healthcare-focused investment firm, today announced that Erik Larsen and Derek Schmidt joined the firm as Managing Directors. The Cabinet also announced the opening of a Nashville, TN Desk.

Larsen joins Concorde of HCA Healthcare, Inc., where he was most recently vice president of the Special Assets Group. As Managing Director, Larsen will leverage his more than 20 years of experience in healthcare investing, investment banking and corporate development to help find new opportunities and improve the investment strategy and business execution. He will report to james olsonFounder and managing partner of Concordeand be located in the new Nashville Desk.

Schmidt was most recently Director of Private Equity for Marquette Associates, where he led the construction of private equity and venture capital programs, including manager selection, co-investment and secondary deployment. At Concord, he will lead the company’s capital formation efforts and focus on Concord’s investor relations, unique asset funds and the development of potential new strategies. He will report to Olsen and be located in Nashville.

“Our mission at Concorde is to build a broad healthcare investment platform that allows us to expand our reach and take advantage of a wider universe of opportunities that create significant value for our investors and our portfolio companies. These great additions to the team and the opening of our Nashville office helps achieve this goal,” said Olsen. “The addition of Erik and Derek’s experience further institutionalizes our team, and I look forward to working closely with them to continue to strengthen our investment process and to work with our strategic LPs to accelerate the growth of our portfolio companies. .”

Concord’s LP’s strategy, expertise and unique foundation have quickly proven to be differentiators in the field of healthcare investing,” said Larsen. “I’m excited about the opportunity to strategically build the team and expand my network in Nashville to help Concorde continue to identify and develop innovative companies and solutions that improve quality of care, reduce costs and improve access to care. »

“I knew the team from Concorde for a number of years in my investor commitment underwriting role, and I look forward to joining the team at such an exciting time for the company and for healthcare investing in general,” said said Schmidt. “I look forward to partnering and engaging with strategic advisors and LPs to proactively identify new opportunities and avenues to drive value across the continuum of care. »

Schmidt and Larsen join Brian Gragnolatiwho is currently president and CEO of Atlantic Health System and former chairman of the board of directors of the American Hospital Association, as recent additions to the Concorde crew. As announced on 11 JulyGragnolati has joined the company as an executive partner, where he will find new investment opportunities, support management teams and accelerate the growth of Concorde portfolio companies through commercial introductions across the Concorde network of strategic relationships.

Nashville has become a true hub of healthcare innovation and talent,” added Olsen. “Establishing a presence there will allow us to better identify, due diligence and execute while continuing to grow and evolve as a business. We look forward to having Erik and Derek on the pitch to help us build our team and our capabilities in the market.”

About Erik Larsen

Larsen has over 20 years of experience in healthcare investing, investment banking and corporate development. before joining ConcordeMr. Larsen served as Vice President of Business Development for the Special Assets Group at HCA Healthcare, Inc. (NYSE: HCA), one of the leading healthcare providers in the United States, operating 186 hospitals and approximately 2,000 healthcare establishments across United States and UK. At HCA Healthcare, Mr. Larsen led the Special Assets Group, including leading the company’s venture capital group (dba Health Insight Capital) from 2017 to 2022. Prior to joining HCA Healthcare in 2011, Mr. Larsen was Director of Development at Renal Advantage, a privately backed ambulatory dialysis provider and an investment banking professional at Morgan Joseph & Co and VelocityHealth Capital, Inc. Mr. Larsen earned a BA from Wake Forest Universityand an MBA from Wake Forest UniversityBabcock Graduate School of Management.

About Derek Schmidt

Schmidt has over 19 years of investment experience in the public and private markets, with over 9 years of dedicated healthcare investing experience. before joining Concorde, he was Director of Private Equity and Principal Research Analyst at Marquette Associates, where he led the construction of private equity and venture capital programs, including manager selection, co-investment and deployment secondary. He was also chairman of the alternative investment committee and member of the OCIO committee. He was responsible for investment manager due diligence and investment performance across all private equity and venture capital programs. Prior to Marquette Associates, Schmidt worked as an equity analyst at Piper Jaffray and as a global partner at William Blair, with a focus on healthcare investing. Previously, he worked in Private Markets at Huron Consulting in their Transaction Advisory Group, where he assisted for-profit and not-for-profit health systems in their acquisitions of health care services and facilities. Schmidt holds a BSBA in Corporate Finance from The Ohio State University. He is a CFA® charter holder and a member of the CFA Institute and the CFA Society of Chicago as well as CAIA charter holder and member of the CAIA Association®. He currently serves on the Board of Directors of the Center Foundation of Anixter Center and serves on both the Investment Committee and the Finance Committee of Anixter Center.

About Concord Health Partners

Concord Health Partners (“Concorde“) is a health-focused investment firm with a strategic model that optimizes the alignment of interests between investors and portfolio companies. Concorde primarily focuses on investing in healthcare businesses that have the potential to improve the value of care through products, services, technologies and solutions that reduce costs, improve quality and expand the Health care access. The company has offices strategically located in Summit, New Jersey and Nashville, Tennessee. For more information, visit www.concordhp.com.

Media Contacts
CSA Advisors
Steve Bruce / Taylor Ingraham
[email protected] / [email protected]
203.992.1230

Concord Health Partners

Share.

About Author

Comments are closed.